Recurrent or Metastatic Solid Tumors Clinical Trials in Seville
2 recruitingSeville, Spain
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo76 enrolled26 locationsNCT07015697
Recruiting
Phase 2
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo520 enrolled119 locationsNCT06330064